The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double-blind, placebo-controlled trial
USA 105 , 21172122 (2008)
GLP-1 receptor agonists can influence acid reflux symptoms, but the relationship is complex and varies significantly by individual
NAD IV therapy may support individuals experiencing chronic fatigue, brain fog, stress, depression, or age-related cognitive decline
The Role of Neuroscience Research At the Neuroscience Research Institute , scientists are actively studying stimulant medications and their effects on brain circuitry
The lipid benefits observed with semaglutide appear to be largely mediated through weight reduction, though some direct effects on lipoprotein metabolism may also contribute